STAT3 is essential for Hodgkin lymphoma cell proliferation and is a target of tyrphostin AG17 which confers sensitization for apoptosis (Q46506090)

22 December 2017

title

STAT3 is essential for Hodgkin lymphoma cell proliferation and is a target of tyrphostin AG17 which confers sensitization for apoptosis (English)

1 reference

22 December 2017

1 reference

U Holtick

1

1 reference

22 December 2017

M Vockerodt

2

1 reference

22 December 2017

D Pinkert

3

1 reference

22 December 2017

N Schoof

4

1 reference

22 December 2017

B Stürzenhofecker

5

1 reference

22 December 2017

N Kussebi

6

1 reference

22 December 2017

K Lauber

7

1 reference

22 December 2017

S Wesselborg

8

1 reference

22 December 2017

D Löffler

9

1 reference

22 December 2017

F Horn

10

1 reference

22 December 2017

L Trümper

11

1 reference

22 December 2017

D Kube

12

1 reference

22 December 2017

publication date

1 June 2005

1 reference

22 December 2017

published in

Leukemia

1 reference

22 December 2017

volume

19

1 reference

22 December 2017

issue

6

1 reference

22 December 2017

page(s)

936-944

1 reference

22 December 2017

https://scigraph.springernature.com/pub.10.1038/sj.leu.2403750

exact match

0 references

cites work

Molecular biology of Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403750

An unbalanced translocation involving chromosome 14 is the probable cause for loss of potentially functional rearranged immunoglobulin heavy chain genes in the Epstein-Barr virus-positive Hodgkin's lymphoma-derived cell line L591.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403750

STAT3 is constitutively activated in Hodgkin cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403750

Linkage between STAT regulation and Epstein-Barr virus gene expression in tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403750

Signal transducer and activator of transcription proteins in leukemias.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403750

Roles of STAT3 in mediating the cell growth, differentiation and survival signals relayed through the IL-6 family of cytokine receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403750

Stat proteins and oncogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403750

Principles of interleukin (IL)-6-type cytokine signalling and its regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403750

Part II: Hodgkin's lymphoma--diagnosis and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403750

Low frequency of FAS mutations in Reed-Sternberg cells of Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403750

Constitutive expression of c-FLIP in Hodgkin and Reed-Sternberg cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403750

Tyrosine kinases as targets for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403750

Inhibition of acute lymphoblastic leukaemia by a Jak-2 inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403750

Constitutive activation of a slowly migrating isoform of Stat3 in mycosis fungoides: tyrphostin AG490 inhibits Stat3 activation and growth of mycosis fungoides tumor cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403750

Curcumin (Diferuloylmethane) Inhibits Constitutive and IL-6-Inducible STAT3 Phosphorylation in Human Multiple Myeloma Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403750

Role of the tyrosine kinase pyk2 in the integrin-dependent activation of human neutrophils by TNF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403750

Inhibition of pancreatic cancer cell growth in vitro by the tyrphostin group of tyrosine kinase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403750

Defective Bax activation in Hodgkin B-cell lines confers resistance to staurosporine-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403750

Nuclear factor kappaB-dependent gene expression profiling of Hodgkin's disease tumor cells, pathogenetic significance, and link to constitutive signal transducer and activator of transcription 5a activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403750

CD40 Ligand--an anti-apoptotic molecule in Hodgkin's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403750

XIAP-mediated caspase inhibition in Hodgkin's lymphoma-derived B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403750

In vivo activation of STAT3 in cutaneous T-cell lymphoma. Evidence for an antiapoptotic function of STAT3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403750

Constitutive nuclear factor-kappaB-RelA activation is required for proliferation and survival of Hodgkin's disease tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403750

Constitutive NF-kappaB maintains high expression of a characteristic gene network, including CD40, CD86, and a set of antiapoptotic genes in Hodgkin/Reed-Sternberg cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403750

Defective IkappaBalpha in Hodgkin cell lines with constitutively active NF-kappaB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403750

Aberrantly expressed c-Jun and JunB are a hallmark of Hodgkin lymphoma cells, stimulate proliferation and synergize with NF-kappa B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403750

MEK/ERK pathway is aberrantly active in Hodgkin disease: a signaling pathway shared by CD30, CD40, and RANK that regulates cell proliferation and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403750

Synergy between interferon-gamma and tumor necrosis factor-alpha in transcriptional activation is mediated by cooperation between signal transducer and activator of transcription 1 and nuclear factor kappaB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403750

Interleukin 1 Activates STAT3/Nuclear Factor-κB Cross-talk via a Unique TRAF6- and p65-dependent Mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403750

Transcriptional activation by STAT6 requires the direct interaction with NCoA-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403750

Hodgkin and Reed-Sternberg cells harbor alterations in the major tumor suppressor pathways and cell-cycle checkpoints: analyses using tissue microarrays

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403750

Single cell analysis of Hodgkin/Reed-Sternberg cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403750

7 January 2021

Signal transducer and activator of transcription 6 is frequently activated in Hodgkin and Reed-Sternberg cells of Hodgkin lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403750

7 January 2021

JAK2 tyrosine kinase inhibitor tyrphostin AG490 downregulates the mitogen-activated protein kinase (MAPK) and signal transducer and activator of transcription (STAT) pathways and induces apoptosis in myeloma cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403750

7 January 2021

Caspase-8/FLICE functions as an executioner caspase in anticancer drug-induced apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403750

7 January 2021

Identifiers

DOI

10.1038/SJ.LEU.2403750

1 reference

22 December 2017

PubMed ID

15912144

1 reference

22 December 2017